BioPharma Credit Balance Sheet Health
Financial Health criteria checks 6/6
Insufficient data to determine the health of BioPharma Credit
Key information
n/a
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$94.71m |
Equity | US$1.36b |
Total liabilities | US$6.90m |
Total assets | US$1.37b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B3P's short term assets ($104.7M) exceed its short term liabilities ($6.3M).
Long Term Liabilities: B3P's short term assets ($104.7M) exceed its long term liabilities ($558.0K).
Debt to Equity History and Analysis
Debt Level: B3P is debt free.
Reducing Debt: B3P has not had any debt for past 5 years.
Debt Coverage: B3P has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: B3P has no debt, therefore coverage of interest payments is not a concern.